Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphoma

Author： Wakao D.   Murohashi I.   Tominaga K.   Yoshida K.   Kishimoto K.   Yagasaki F.   Itoh Y.   Itoh K.   Sakata T.   Kawai N.   Kayano H.   Suzuki T.   Matsuda A.   Hirashima K.   Bessho M.  

Publisher： Springer Publishing Company

ISSN： 0939-5555

Source： Annals of Hematology, Vol.81, Iss.3, 2002-03, pp. : 140-146

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Serum thymidine kinase 1 levels predict cancerfree survival following neoadjuvant, surgical and adjuvant treatment of patients with locally advanced breast cancer

By                    

Molecular and Clinical Oncology, Vol. 1, Iss. 5, 2013-01 ,pp. : 894-902

Spandidos Publications

Access to resources Recommend Favorite

Serum Neopterin, &bgr;2-Microglobulin, Soluble Interleukin-2 Receptors, and Immunoglobulin Levels in Healthy Adolescents

By Satoh T.   Brown L.M.   Blattner W.A.   Maloney E.M.   Kurman C.C.   Nelson D.L.   Fuchs D.   Wachter H.   Tollerud D.J.  

Clinical Immunology, Vol. 88, Iss. 2, 1998-08 ,pp. : 176-182

Academic Press

Access to resources Recommend Favorite

The effect of montelukast on soluble interleukin-2 receptor and tumor necrosis factor α in pediatric asthma

By Can Murat   Yüksel Birol   Demirtaş Selda   Tomaç Nazan  

Allergy and Asthma Proceedings, Vol. 27, Iss. 4, 2006-07 ,pp. : 383-386

OceanSide Publications, Inc

Access to resources Recommend Favorite

Interleukin 6 and its soluble receptor are elevated in aqueous humor of patients with uveitis

By Petrinovicc-Dorešic Jelena   Mazuran Renata   Henc-Petrinovic Ljerka   Kuzmanovic Biljana   Jovicic Aleksandra  

Ocular Immunology and Inflammation, Vol. 7, Iss. 2, 1999-06 ,pp. : 75-84

Informa Healthcare

Access to resources Recommend Favorite

Interleukin-1β, Interleukin-1 Receptor Antagonist, and Soluble Interleukin-1 Receptor Type II Secretion in Chronic Fatigue Syndrome

By Cannon Joseph G.   Angel Jonathan B.   Abad Leslie W.   Vannier Edouard   Mileno Maria D.   Fagioli Laura   Wolff Sheldon M.   Komaroff Anthony L.  

Journal of Clinical Immunology, Vol. 17, Iss. 3, 1997-05 ,pp. : 253-261

Springer Publishing Company

Access to resources Recommend Favorite